Ekso Bionics Holdings, Inc. (OTCBB:EKSO) Surges On PR
[[tagnumber 0]][[tagnumber 1]]The first half of the year has just shown how volatile Ekso Bionics Holdings, Inc. (OTCBB:EKSO) can be. The ticker blasted through the $2 per share mark in the start of April, but subsequently came down. Another climb brought it back above 2 dollars in the second half of May which showed that [[tagnumber 2]]EKSO[[tagnumber 3]] can’t stand the pressure and the ticker almost dropped below $1 per share in the end of June.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]It has had a hard time keeping its price since then, which isn’t something strange considering the fact that the company has quite the market cap, despite the fact that it shows some impressive progress and quite positive financial results. Here is just a quick reminder at what [[tagnumber 2]]EKSO[[tagnumber 3]] had to show in the end of the first quarter of the year.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 13]] [[tagnumber 14]]cash: $21.13 million[[tagnumber 15]] [[tagnumber 14]]current assets: $25.55 million[[tagnumber 15]] [[tagnumber 14]]current liabilities: $6.7 million[[tagnumber 15]] [[tagnumber 14]]quarterly revenues: $1.68 million[[tagnumber 15]] [[tagnumber 14]]quarterly net loss: $4.11 million[[tagnumber 15]] [[tagnumber 24]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]Those are certainly some impressive numbers for an OTC entity and [[tagnumber 2]]EKSO[[tagnumber 3]] has much more to add to this. The company has been working on the development of exoskeletons for all types of uses. From the military, to the industry and healthcare, exoskeletons can be used for a variety of purposes.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]The company is even involved with Boston Dynamics in a Defense Advanced Research Projects Agency (DARPA) development projects and has already stepped into the rehabilitation field, expanding its business.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]Yesterday we saw Nathan Harding, CEO of [[tagnumber 2]]EKSO[[tagnumber 3]] interviewed by Stuart Varney on the Varney & Co. program broadcasted on the Fox Business Network program. This led to a decent 11.78% jump and [[tagnumber 2]]EKSO[[tagnumber 3]] finished the session at $1.14 with a total of 667 thousand traded shares and a daily dollar volume of $721 thousand.[[tagnumber 4]] [[tagnumber 0]] [[tagnumber 4]] [[tagnumber 0]]Despite all the positive attention that [[tagnumber 2]]EKSO[[tagnumber 3]] has received, however, we see the ticker is hesitating in today’s session. As always, it is crucial that you do your due diligence and weigh out all the risks before putting any money on the line.[[tagnumber 4]]